Application no. and date | 03752058.2 (espacenet) (Federated) (European Patent Register), 20030905 | Patent/reg. no. and date | DK/EP 1572946, 20120314 | Publication date | 20050914 | Priority no. and date | US 408719 P, 20020906 | EP pub. no. and date |
EP 1572946 20050914 | Effective date | | Applicant/owner | Amgen, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US, E. R. Squibb & Sons, L.L.C., Route 206 & Province Line Road
Princeton, NJ 08540, US | Applicant ref. no. | 63401 | Inventor | VARNUM, Brian, 602 12th Street
Santa Monica, CA 90402, US, VEZINA, Chris, 351 South Greenway Avenue
Newbury Park, CA 91320, US, QIAN, Xueming, 596 Myrtle Court
Oak Park, CA 91320, US, ELLIOTT, Gary, 2458 Chaucer Place
Thousand Oaks, CA 91362, US, HUANG, Haichun, 2425 Sueno Way
Fremont, CA 94539, US, MARTIN, Frank, 865 Fernhill Court
Newbury Park, CA 91320, US, WITTE, Alison, 3505 Bean Creek Road
Scotts Valley, CA 95066, US | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | Title | Terapeutisk humant monoklonalt anti-IL-1R1-antistof | Int. application no. | US2003027978 | Int. publication no. | WO2004022718 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|